Skip to main content

Vor Bio to Participate in the Wedbush PacGrow Healthcare Conference

CAMBRIDGE, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, will host in-person 1x1 investor meetings at the 2023 Wedbush PacGrow Healthcare Conference.

Wedbush PacGrow Healthcare Conference
1x1 Investor Meetings: August 8-9, 2023
Location: Lotte Palace Hotel, New York, NY

About Vor Bio
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

Contact:

Media & Investors
Sarah Spencer
+1 857-242-6076
sspencer@vorbio.com


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  234.97
-2.61 (-1.10%)
AAPL  272.37
-0.58 (-0.21%)
AMD  246.61
-1.35 (-0.54%)
BAC  52.59
-0.28 (-0.54%)
GOOG  276.97
-2.15 (-0.77%)
META  609.62
-0.27 (-0.04%)
MSFT  509.72
+6.43 (1.28%)
NVDA  190.18
+3.31 (1.77%)
ORCL  223.13
+5.56 (2.56%)
TSLA  404.64
+2.65 (0.66%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.